Horarios de alimentación y sueño en adolescentes chilenos de San Antonio, V Región: su asociación con obesidad y distribución de adiposidad corporal / Feeding hours and sleep in chilean adolescents of San Antonio, V Region: it association with obesity and corporal adiposity distribution

Introducción: La obesidad es un problema mundial de salud. El desayuno parece asociarse con un menor IMC en adolescentes, pero hay poca evidencia en nuestro medio del riesgo de obesidad general o abdominal según la cantidad de comidas diarias y las horas de sueño. Objetivo: Estudiar la asociación entre los horarios de alimentación y de sueño y el riesgo de obesidad y adiposidad en adolescentes chilenos. Sujetos y métodos: Estudio transversal en 290 adolescentes (12-19 años) de un colegio municipal de San Antonio, V Región de Chile. Se les evaluó el IMC, la circunferencia abdominal (CA), la adiposidad general (AG) y se completó una encuesta de frecuencia de consumo y sueño. Resultados: En niñas hubo más obesidad en aquellas con <3 comidas/día vs con >4 comidas/día (9,4 vs 0,7%; OR= 7,6; IC95%: 1,8-44,0), también en varones (17,7% vs 2,6%; OR=9,8; IC 95%: 2,941,3). En mujeres la CA fue mayor con <3 vs >4 comidas/día (83,8±10,9 vs 73,3± 6,6 cm; p<0,05); lo mismo en varones (81,2± 9,5 cm vs 75,5± 6,3 cm; p<0,05). Un 38,8% de los varones tenían AG aumentada con <3 comidas/día vs 7,2% con >4 comidas/día (OR= 10,5; IC95%: 3,3-35,1). Los varones que dormían < 9 h/d presentaron >IMC que los con > 9 h/d: 22,8± 3,9 vs 21,5± 3,9 Kg/m² (p<0,05). El análisis multivariado mostró al numero de comidas/día como el principal factor asociado a obesidad. Conclusiones: En estos adolescentes la frecuencia de comidas <3/día se asoció con un mayor riesgo de adiposidad y de obesidad central y en varones además con < 9 h/d de sueño.

Background: Obesity is a global health problem. Eating breakfast maybe associated with a lower risk of obesity in adolescents; scarce evidence is available in our country about risk of obesity associated to the frequency of daily meals or shortened sleep. Objective: To evaluate the association among daily meals and sleeping schedules and risk of adiposity and obesity in Chilean adolescents. Subjects and methods: In a cross-sectional study, 290 adolescents (12- 19 y), attending to a public school in San Antonio city Chile, were evaluated for nutritional status, daily meal schedule and sleep. Results: Obesity was greater in females consuming <3 meals/day vs >4 meals/day (9.4% vs 0.7%; OR= 7.6 IC95%:l.8-44.0); also in males (17.7% vs 2.6%; OR=9.8 IC 95% :2.9-41.3). Abdominal circumference was higher in females consuming <3 meals/day than those with >4 meals/day (83.8±I0.9 vs 73.3± 6.6 cm; (p<0.05), and also in males (81.2± 9.5 vs 75.5± 6.3 cm; p<0.05); 38.8% of males with <3 meals/day had increased body fat vs 7.2% in those consuming>4 meals/day (OR= 10.5 IC95%: 3.3-35.1). Males sleeping < 9h/d exhibited > BMI: 22.8± 3.9 vs 21.5± 3.9 Kg/m² (p<0.05). Multivariate analysis showed the number of daily meals as the only factor associated with obesity. Conclusions: In these Chilean adolescents, low amount of daily meals is the main factor associated to obesity, to adiposity and to abdominal circumference, and few hours of sleep/day only for males.

Hiperuricemia y componentes del síndrome metabólico en niños y adolescentes obesos / Hyperuricaemia and metabolic syndrome in obese children and adolescents

Introducción: La hiperuricemia se ha observado como una alteración metabólica adicional en pacientes adultos obesos, pero es poco conocida su magnitud en pacientes pediátricos. Objetivos: Analizar la asociación entre ácido úrico sérico (AUS) con magnitud de la obesidad general y visceral y con otras mediciones bioquímicas en niños y adolescentes obesos de Santiago, Chile. Sujetos y método: En un estudio transversal se evaluaron 770 niños (edades: 6-15 años) de un colegio público de Santiago, Chile, encontrando 227 obesos (29%) (IMC > 2 DE, estándares OMS). Se seleccionaron aleatoriamente 90 niños y aceptaron participar 77, sin otras enfermedades crónicas. Se evaluó: peso, talla, perímetro abdominal, adiposidad visceral con ultrasonografía abdominal y mediciones metabólicas: insulinemia, glucemia (HOMA), lípidos séricos, aspartato aminotransferasa, alanina aminotransferasa (ALT) y AUS. Resultados: Las concentraciones de AUS fueron 0,200 ± 0,065 mmol/l. El AUS fue mayor en niños con valores de hiperinsulinismo (ajustado según edad): 0,221 ± 0,075 vs 0,183 ± 0,054 mmol/l (p < 0,01), sin diferencias según HOMA; las diferencias también se observaron según ALT (> vs < 26 U/ml): 0,238 ± 0,070 vs 0,178 ± 0,054 mmol/l, p < 0,001; la regresión logística controlando por sexo, edad e intensidad de la obesidad mostró solo las ALT asociadas a aumento de AUS. No hubo asociación de mayor AUS con magnitud de IMC, adiposidad visceral o hígado graso. Conclusiones: Los niños y adolescentes obesos de Santiago, Chile, tienen una uricemia mayor en asociación a un aumento de la actividad de la enzima ALT e hiperinsulinismo. Se justifica analizar uricemia en el estudio de niños obesos y en su seguimiento.

Introduction: Hyperuricaemia has been suggested as an additional metabolic factor in adult obese patients, but it has not been sufficiently studied in paediatric. Objectives: To assess the relationship between serum uric acid levels (SUAL) with the level of general and visceral obesity, and other biochemical parameters in children and adolescents of Santiago, Chile. Subjects and method: A cross sectional study was conducted on 770 children and adolescents (ages: 6-15 y.) from a public school in Santiago, Chile, of whom 227 (29%) were obese (BMI > 2 SD, WHO growth standards). Ninety subjects were randomly selected and 77 with no other chronic disease (41 males) accepted to participate. Data was collected on weight, stature, abdominal circumference (AC), visceral adiposity using ultrasound, and other biochemical measurements including fasting glucose, insulin, serum lipids, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and SUAL. Results: The mean SUAL was 0.200 ± 0.065 mmol/L, and was increased in children with hyperinsulinism (adjusted by age: 0.221 ± 0.075 vs 0.183 ± 0.054 mmol/L; P < .01), with no significant differences according to HOMA. Differences were also found between children with ALT > or < 26 U/mL: 0.238 ± 0.070 vs 0.178 ± 0.054 mmol/L, P < .001. The logistic regression showed the increased SUAL was only associated with increased ALT. No significant differences were found in general or visceral adiposity measurements or fatty liver. Conclusions: Children and adolescents from Santiago, Chile have higher uric acid serum uric acid levels as well as an association with increased ALT and insulin. It is demonstrated in this study that uric acid should be measured in obese children and adolescents, and in their follow up.

[Hyperuricaemia and metabolic syndrome in obese children and adolescents]. / Hiperuricemia y componentes del síndrome metabólico en niños y adolescentes obesos.

INTRODUCTION: Hyperuricaemia has been suggested as an additional metabolic factor in adult obese patients, but it has not been sufficiently studied in paediatric. OBJECTIVES: To assess the relationship between serum uric acid levels (SUAL) with the level of general and visceral obesity, and other biochemical parameters in children and adolescents of Santiago, Chile. SUBJECTS AND METHOD: A cross sectional study was conducted on 770 children and adolescents (ages: 6-15 y.) from a public school in Santiago, Chile, of whom 227 (29%) were obese (BMI>2 SD, WHO growth standards). Ninety subjects were randomly selected and 77 with no other chronic disease (41 males) accepted to participate. Data was collected on weight, stature, abdominal circumference (AC), visceral adiposity using ultrasound, and other biochemical measurements including fasting glucose, insulin, serum lipids, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and SUAL. RESULTS: The mean SUAL was 0.200±0.065 mmol/L, and was increased in children with hyperinsulinism (adjusted by age: 0.221±0.075 vs. 0.183±0.054 mmol/L; P<.01), with no significant differences according to HOMA. Differences were also found between children with ALT>or<26 U/mL: 0.238±0.070 vs. 0.178±0.054 mmol/L, P<.001. The logistic regression showed the increased SUAL was only associated with increased ALT. No significant differences were found in general or visceral adiposity measurements or fatty liver. CONCLUSIONS: Children and adolescents from Santiago, Chile have higher uric acid serum uric acid levels as well as an association with increased ALT and insulin. It is demonstrated in this study that uric acid should be measured in obese children and adolescents, and in their follow up.

Efecto de la suplementación con vitamina D en monodosis en niños con parálisis cerebral: Estudio preliminar controlado y aleatorizado / Effect of supplementation with a single dose of vitamin D in children with cerebral palsy: Preliminary randomised controlled study

Introducción: Los niños con parálisis cerebral (PC) tienen mayor riesgo de deficiencia de vitamina D (VD). Aunque existen bastantes estudios sobre VD en PC, hay limitada información sobre suplementación con VD en estos pacientes. Objetivo: Evaluar el efecto de la suplementación con VD en monodosis en las concentraciones plasmáticas de 25-hidroxi-vitamina-D (25OHD) en niños con PC. Pacientes y método: Estudio controlado, prospectivo y aleatorizado. Se estudiaron 30 niños chilenos (19 varones) con PC, mediana de edad de 9,9 años (6,2-13,5). Se registraron las variables clínicas y bioquímicas incluyendo 25OHD (tiempo 0 y 8 semanas). El grupo suplementado (S) recibió 100.000 UI D3 oral (tiempo 0), comparado con el grupo placebo (P). Resultados: Entre las características clínicas destaca: gastrostomizados (60%), desnutrición (30%), postración (93,3%), uso de antiepilépticos (70%) y uso de antiepilépticos inductores del metabolismo de VD (43,3%). Las mediciones basales de variables bioquímicas fueron normales. La 25OHD fue insuficiente en 4/30 y deficiente en 6/30. No hubo asociación de 25OHD con las variables estudiadas. Completaron el estudio 8 pacientes en el grupo S y 10 en el P. En ambos grupos no se observaron diferencias significativas en las variables basales. A las 8 semanas la calcemia, la fosfemia y la fosfatasa alcalina fueron normales en ambos grupos, la 25OHD en el grupo P fue normal en 6/10 e insuficiente + deficiente en 4/10 y normal en 8/8 en el grupo S (test exacto de Fisher, p = 0,07). Conclusiones: Una monodosis de 100.000 UI de VD podría normalizar las concentraciones de 25OHD en niños con PC. Se necesitan más estudios para confirmar estos resultados.

Introduction: Children with cerebral palsy (CP) have an increased risk of vitamin D (VD) deficiency. Although there are many studies on VD and CP, there is limited information about VD supplementation in these patients. Objective: To evaluate the effect of supplementation with a single dose of VD on the plasma concentrations of 25-hydroxy-vitamin-D (25OHD) in children with CP. Patients and method: Prospective-randomised-controlled-trial, including 30 Chilean children (19 males) with CP, median age 9.9 years (6.2-13.5). Clinical and biochemical variables including 25OHD, were recorded (time 0 and 8 weeks). Patients were allocated to the supplemented (S) group receiving 100,000 IU oral D3 at baseline, and compared with the placebo (P) group. Results: Among clinical features are highlighted: gastrostomy (60%), underweight (30%), bedridden (93.3%), antiepileptic drugs (70%), and 43.3% used VD metabolism inducing antiepileptics. Baseline biochemical measurements were normal. The 25OHD was insufficient in 4/30 and deficient in 6/30. 25OHD levels were not associated with the variables studied. Eight patients completed the study in the S group, and 10 in P group. The placebo and supplementation groups had no significant difference in baseline variables. Serum calcium, phosphate, and alkaline phosphatase levels at 8 weeks were normal in both groups, with no statistically significant differences. 25OHD in the P group was normal in 6/10, and insufficient + deficient in 4/10, and the S group was normal in all (8/8) (exact Fisher test P = .07). Conclusions: A single dose of 100,000 IU VD could normalise the concentrations of 25OHD after 8 weeks of supplementation in Children with CP, but more studies are required to confirm these results.

[Effect of supplementation with a single dose of vitamin D in children with cerebral palsy. Preliminary randomised controlled study]. / Efecto de la suplementación con vitamina D en monodosis en niños con parálisis cerebral. Estudio preliminar controlado y aleatorizado.

INTRODUCTION: Children with cerebral palsy (CP) have an increased risk of vitamin D (VD) deficiency. Although there are many studies on VD and CP, there is limited information about VD supplementation in these patients. OBJECTIVE: To evaluate the effect of supplementation with a single dose of VD on the plasma concentrations of 25-hydroxy-vitamin-D (25OHD) in children with CP. PATIENTS AND METHOD: Prospective-randomised-controlled-trial, including 30 Chilean children (19 males) with CP, median age 9.9 years (6.2-13.5). Clinical and biochemical variables including 25OHD, were recorded (time 0 and 8 weeks). Patients were allocated to the supplemented (S) group receiving 100,000 IU oral D3 at baseline, and compared with the placebo (P) group. RESULTS: Among clinical features are highlighted: gastrostomy (60%), underweight (30%), bed-ridden (93.3%), antiepileptic drugs (70%), and 43.3% used VD metabolism inducing antiepileptics. Baseline biochemical measurements were normal. The 25OHD was insufficient in 4/30 and deficient in 6/30. 25OHD levels were not associated with the variables studied. Eight patients completed the study in the S group, and 10 in P group. The placebo and supplementation groups had no significant difference in baseline variables. Serum calcium, phosphate, and alkaline phosphatase levels at 8 weeks were normal in both groups, with no statistically significant differences. 25OHD in the P group was normal in 6/10, and insufficient+deficient in 4/10, and the S group was normal in all (8/8) (exact Fisher test P=.07). CONCLUSIONS: A single dose of 100,000 IU VD could normalise the concentrations of 25OHD after 8 weeks of supplementation in Children with CP, but more studies are required to confirm these results.

Migraciones en países de América Latina: Características de la población pediátrica / Migrations in Latin American countries: Characteristics of the pediatric population Abstract

Introducción: Las migraciones constituyen un fenómeno creciente en América Latina (AL), pero hay poca información sobre la magnitud en población pediátrica y asociación con variables sociodemográficas. Objetivo: Estudiar la asociación de variables sociodemográficas con la tasa de inmigración de población pediátrica en países de AL. Material y métodos: Se buscó información sobre migraciones en países de AL en: Organización Internacional para Migraciones, Organización Panamericana de la Salud y Programa de Naciones Unidas para el Desarrollo. Se efectuaron correlaciones o comparación entre países de variables económicas y demográficas: ingreso nacional bruto per cápita (INB), índice de desarrollo humano (IDH), coeficiente de desigualdad Gini (CG) y tasa de alfabetización (% adultos alfabetizados, TA), con tasa neta de migración por país (TNM) y de niños < 15 años (IN15). Resultados: La TNM fue positiva para Costa Rica, Panamá, Venezuela, Chile y Argentina. No observamos asociación entre TNM con: INB, IDH, CG y TA. Hubo una asociación de IN15 con CG (r = 0,668, p = 0,01), con INB (r = -0,720; p = 0,01), con TA (r = -0,755; p = 0,01) y con IDH (r = -0,799; p = 0,01). La IN15 fue más baja en países de AL con mayor INB vs. aquellos con menor INB (Fisher, p < 0,0001). Conclusiones: Hay una asociación inversa entre INB per cápita, IDH, TA y directa del CG, con la proporción de IN15 de cada país. No observamos una asociación entre TNM con IDH, TA, CG. Debe analizarse el impacto en salud de estas migraciones infantiles.

Introduction: Migration is a growing phenomenon among Latin American countries (LAC) as well as others; however, scarce information is available studying its impact on paediatric groups and its association with socioeconomic variables. Objective: To study the association among socioeconomic variables and the immigration rate of paediatric population in LAC. Material and methods: Official rates of migration of LAC were obtained from: International Organization for Migration, Pan American Health Organization, and United Nations Development Programme. Demographic and socioeconomic information was also obtained for: gross domestic product (GDP), human development index (HDI), Gini coefficient of inequality (GC), alphabetization rate for adults (AA), net migration rate (NMR), and immigration of children < 15 years (IM15). Description, linear correlations and analysis of differences between groups of countries were assessed. Results: The NMR was positive for Costa Rica, Panama, Venezuela, Chile and Argentina. No association among NMR and GDP, HDI, GC, AA was found. A correlation of IM15 was found with: GC (r = 0.668, P = .01), with GDP (r = -0.720; P = .01), AA (r = -0.755; P = .01) and with HDI (r = -0.799; P = .01). Rate of IM15 was lower in LA countries with advanced/medium development (GDP> median) vs those with low development (Fisher, P < .0001). Conclusions: There is a direct inverse association between GDP per capita, HDI, AA and GC and the proportion of each country IN15. We did not observe an association between NMR and HDI, AA, and GC. The health impact of these migrations should be analysed.

[Migrations in Latin American countries. Characteristics of the pediatric population]. / Migraciones en países de América Latina. Características de la población pediátrica.

INTRODUCTION: Migration is a growing phenomenon among Latin American countries (LAC) as well as others; however, scarce information is available studying its impact on paediatric groups and its association with socioeconomic variables. OBJECTIVE: To study the association among socioeconomic variables and the immigration rate of paediatric population in LAC. MATERIAL AND METHODS: Official rates of migration of LAC were obtained from: International Organization for Migration, Pan American Health Organization, and United Nations Development Programme. Demographic and socioeconomic information was also obtained for: gross domestic product (GDP), human development index (HDI), Gini coefficient of inequality (GC), alphabetization rate for adults (AA), net migration rate (NMR), and immigration of children<15 years (IM15). Description, linear correlations and analysis of differences between groups of countries were assessed. RESULTS: The NMR was positive for Costa Rica, Panama, Venezuela, Chile and Argentina. No association among NMR and GDP, HDI, GC, AA was found. A correlation of IM15 was found with: GC (r=0.668, P=.01), with GDP (r=-0.720; P=.01), AA (r=-0.755; P=.01) and with HDI (r=-0.799; P=.01). Rate of IM15 was lower in LA countries with advanced/medium development (GDP>median) vs those with low development (Fisher, P<.0001). CONCLUSIONS: There is a direct inverse association between GDP per capita, HDI, AA and GC and the proportion of each country IN15. We did not observe an association between NMR and HDI, AA, and GC. The health impact of these migrations should be analysed.

¿Hay una asociación entre deficiencia de vitamina D y riesgo de bronquiolitis y asma bronquial en la infancia?: Una revisión crítica / Is there a relation between vitamin D deficiency and an increased risk for bronchiolitis and bronchial asthma in childhood?: A critical revision

Se revisa críticamente la información científica relacionada con deficiencia de vitamina D (DVD) y riesgo de infecciones respiratorias agudas bajas (IRAB) o asma bronquial en niños. Las IRAB, en especial por virus respiratorio sincicial (VRS) están asociadas a una alta carga de enfermedad. Al no contar aún con una vacuna para ellas, las medidas preventivas y de sostén son las más importantes. El DVD es prevalente en todos los ambientes geográficos, con consecuencias ligadas al metabolismo de calcio y óseo, pero también alteraciones de la inmunidad. Hay evidencia inicial de una asociación entre DVD y mayor riesgo de IRAB, especialmente durante los primeros meses de vida; alelos de algunos polimorfismos del receptor de vitamina D podrían asociarse a un mayor riesgo de IRAB. Este escenario cosmopolita, justifica estudiar el impacto de medidas de suplementación de VD adaptadas a las realidades locales, a la madre durante el embarazo y/o al niño en los primeros meses de vida, que impacten sobre el riesgo de presentar IRAB y asma.

We critically review the information about vitamin D deficiency (VDD) and risk of lower respiratory infections and asthma in children. Acute lower respiratory infections (ALRI), particularly those due to respiratory syncytial virus (RSV) are associated with a high burden of disease. In theabsence of a vaccine for them, prevention and support during illness are important measures to reduce the risk of acquiring the condition or decreasing its severity. VDD has been described as prevalent in all geographical environments; its consequences are linked to calcium and bone metabolism, but also to impaired immunity. Recent evidence of an association between VDD and increased risk of ALRI, especially during the first few months of life has been demonstrated; alleles of some polymorphism of vitamin D receptor may be involved in an increased risk of LRTI. It is justified to study the impact of measures of vitamin D supplementation adapted to local environments, including the appropriate doses to the mother during pregnancy and/or to the child in the first months of life, on the risk of ALRI, or asthma in later ages.

Deficiencia de micronutrientes y enfermedad celíaca en pediatría / Micronutrient deficiencies and celiac disease in Pediatrics

La enfermedad celíaca (EC) parece estar cambiando en su clínica, desde formas diarreicas con desnutrición hasta aquellas con clínica más silente y más tardía. La enteropatía de la EC ocurre con malabsorción de macro- y micronutrientes, que incluyen Fe, Zn, Cu, folato, Ca, vitaminas E, D, B12 y B6, con mecanismos de transporte alterados. La anemia ferropriva se ha descrito en EC como única manifestación o como la manifestación extraintestinal más frecuente. La deficiencia de Zn es frecuente en EC, asociada a un retraso de crecimiento y alteraciones inmunitarias. La malabsorción intestinal puede comprometer la absorción de vitamina D, aunque su aporte dietario es responsable solo del 20% de las concentraciones séricas, por lo que lo importante es la exposición dérmica al sol. La causa de deficiencia de vitamina B12 en EC es desconocida; debe considerarse ante alteraciones neurológicas y hematológicas. La deficiencia de Cu se ha descrito de preferencia en celíacos adultos. Se concluye que, en el seguimiento de la EC, debiera estudiarse periódicamente la deficiencia de micronutrientes por sus consecuencias a largo plazo; debe sospecharse una EC ante signos clínicos no explicados de deficiencia de micronutrientes.

Celiac disease (CD) is apparently changing in its clinical presentation, from chronic diarrhea and malnutrition to a silent clinic at older ages. The basal enteropathy of CD induces macro-and micronutrient malabsorption. Described micronutrient deficiencies in CD include: Fe, Zn, Cu, folate, Ca, vitamin E, D, B12 and B6, with complex transporter mechanisms altered. Ferropenic anemia has been described in CD as the exclusive sign and the most common extraintestinal sign. Zn deficiency is frequent in CD, associated with growth delay and immune alterations. Even though the main basis for vitamin D metabolic status is the activation of subdermal vitamin precursors by sun-UVB rays, the small bowel compromise may affect activity and vitamin D absorption. Pathophysiology of vitamin B12 deficiency in CD is unknown; it must be suspected in CD patients presenting neurological and haematological alterations. Copper deficiency has been described mainly in adult CD patients. Micronutrient deficiencies should be periodically studied through the CD follow-up; celiac disease must be studied if clinical signs of micronutrient deficiencies are diagnosed.

[Micronutrient deficiencies and celiac disease in Pediatrics]. / Deficiencia de micronutrientes y enfermedad celíaca en pediatría.

Celiac disease (CD) is apparently changing in its clinical presentation, from chronic diarrhea and malnutrition to a silent clinic at older ages. The basal enteropathy of CD induces macro-and micronutrient malabsorption. Described micronutrient deficiencies in CD include: Fe, Zn, Cu, folate, Ca, vitamin E, D, B12 and B6, with complex transporter mechanisms altered. Ferropenic anemia has been described in CD as the exclusive sign and the most common extraintestinal sign. Zn deficiency is frequent in CD, associated with growth delay and immune alterations. Even though the main basis for vitamin D metabolic status is the activation of subdermal vitamin precursors by sun-UVB rays, the small bowel compromise may affect activity and vitamin D absorption. Pathophysiology of vitamin B12 deficiency in CD is unknown; it must be suspected in CD patients presenting neurological and haematological alterations. Copper deficiency has been described mainly in adult CD patients. Micronutrient deficiencies should be periodically studied through the CD follow-up; celiac disease must be studied if clinical signs of micronutrient deficiencies are diagnosed.

Deficiencia de micronutrientes y enfermedad celíaca en pediatría. / [Micronutrient deficiencies and celiac disease in Pediatrics].

Celiac disease (CD) is apparently changing in its clinical presentation, from chronic diarrhea and malnutrition to a silent clinic at older ages. The basal enteropathy of CD induces macro-and micronutrient malabsorption. Described micronutrient deficiencies in CD include: Fe, Zn, Cu, folate, Ca, vitamin E, D, B12 and B6, with complex transporter mechanisms altered. Ferropenic anemia has been described in CD as the exclusive sign and the most common extraintestinal sign. Zn deficiency is frequent in CD, associated with growth delay and immune alterations. Even though the main basis for vitamin D metabolic status is the activation of subdermal vitamin precursors by sun-UVB rays, the small bowel compromise may affect activity and vitamin D absorption. Pathophysiology of vitamin B12 deficiency in CD is unknown; it must be suspected in CD patients presenting neurological and haematological alterations. Copper deficiency has been described mainly in adult CD patients. Micronutrient deficiencies should be periodically studied through the CD follow-up; celiac disease must be studied if clinical signs of micronutrient deficiencies are diagnosed.

Alimentación normal del niño menor de 2 años: recomendaciones de la rama de nutrición de la sociedad chilena de pediatría 2013 / Nutrition in childhood: guides of the nutrition branch, chilean society of pediatrics

Los modos de alimentación adquiridos por el lactante son centrales para su crecimiento y desarrollo, así como para la disminución del riesgo de diversas enfermedades crónicas; pueden alterar además las preferencias alimentarias en otras edades. La obesidad, las alergias y otras enfermedades crónicas asociadas a la nutrición han pasado a ser los problemas más prevalentes en los niños chilenos. Hay abundante evidencia científica reciente tanto internacional como nacional acerca de los modos de alimentación del lactante, que están haciendo indispensable una actualización de las guías chilenas de alimentación del año 2004. Este artículo actualiza y propone nuevas recomendaciones de alimentación para población chilena durante los primeros dos años de vida.

Infant feeding habits are essential for child growth and development, as well as reducing various chronic disease risks; they can also alter later preferences of food. Obesity, allergies and other chronic diseases related to nutrition have become the most frequent problems in Chilean children. There is a lot of recent evidence, both international and domestic, about infant feeding habits, which forces an update to the 2004 Chilean guidelines. This study updates and proposes new feeding recommendations for the Chilean population during the first two years of life.

[Vitamin D nutrition in Chilean pre-school children living in extreme latitudes]. / Estado nutricional de vitamina D en pre escolares chilenos de zonas australes.

BACKGROUND: Sunlight exposure is the main factor for adequate vitamin D (VitD) nutrition; in extreme latitudes there is an increased risk for its deficiency. AIM: To study VitD nutritional status in pre-school children living in austral latitudes of Chile. SUBJECTS AND METHODS: A blood sample was obtained from 60 pre-school healthy children (aged 2 to 5 years, 24 males), attending to public day-care centers in Coyhaique (45° 35' S), during March (time 1) and September (time 2). 250 HD, parathyroid hormone (PTH), calcium, phosphate and alkaline phosphatases (PA) were measured. Information about weather conditions during three months prior to the sample withdrawal was gathered. RESULTS: Forty nine percent of children had a normal weight and 11% were overweight. Vive children with unreliable 250 HD levels were excluded from analysis. At time 1, 250 HD levels were 21.6 ± 14.5 ngl mh (7.9-71.1). Sixty four percent of children had valúes < 20 ng/mL (deficiency). At time 2, the figures were 21.5 ± 13.2 ng/mL (9.4-68.5) and 67.3% of children were deficient. PTH, serum calcium, phosphate and PA were normal. Prior to time 1, the UVradiation Índex (UVI) was high to extreme (91.3%), with 3.3 and 73% of sunny and cloudy days, respectively. Mean minimal and maximal temperatures were 7 and 17.3°C respectively. Prior to time 2 the IUVwas low in 100%) of days; with 15.2 and 60.9 of sunny and cloudy days, respectively. Mean minimal and maximal temperatures were 0.3 and 6.7°C respectively. No association of 250 HD with the other metabolicparameters was found. CONCLUSIONS: Chilean pre-school children living in austral latitudes have a high rate of vitamin D deficiency, throughout the year, with no association with PTH, calcium, phosphate or PA. Further research is required to study vitamin D deficiency in other latitudes and magnitude of sunlight exposure.

Estado nutricional de vitamina D en pre escolares chilenos de zonas australes / Vitamin D nutrition in Chilean pre-school children living in extreme latitudes

Background: Sunlight exposure is the main factor for adequate vitamin D (VitD) nutrition; in extreme latitudes there is an increased riskfor its deficiency. Aim: To study VitD nutritional status in pre-school children living in austral latitudes of Chile. Subjects and Methods: A blood sample was obtained from 60 pre-school healthy children (aged 2 to 5years, 24 males), attending to public day-care centers in Coyhaique (45° 35' S), during March (time 1) and September (time 2). 250HD, parathyroid hormone (PTH), calcium, phosphate and alkaline phosphatases (PA) were measured. Information about weather conditions during three months prior to the sample withdrawal was gathered. Results: Forty nine percent of children had a normal weight and 11% were overweight. Vive children with unreliable 250HD levels were excluded from analysis. At time 1, 250HD levels were 21.6 ± 14.5 ngl mh (7.9-71.1). Sixty four percent of children had valúes < 20 ng/mL (deficiency). At time 2, the figures were 21.5 ± 13.2 ng/mL (9.4-68.5) and 67.3% of children were deficient. PTH, serum calcium, phosphate and PA were normal. Prior to time 1, the UVradiation Índex (UVI) was high to extreme (91.3%), with 3.3 and 73% ofsunny and cloudy days, respectively. Mean minimal and maximal temperatures were 7 and 17.3°C respectively. Prior to time 2 the IUVwas low in 100%) ofdays; with 15.2 and 60.9 ofsunny and cloudy days, respectively. Mean minimal and maximal temperatures were 0.3 and 6.7°C respectively. No association of250HD with the other metabolicparameters was found. Conclusions: Chilean pre-school children living in austral latitudes have a high rate of vitamin D deficiency, throughout theyear, with no association with PTH, calcium, phosphate or PA. Further research is required to study vitamin D deficiency in other latitudes and magnitude of sunlight exposure.

Embarazo y parto en madres inmigrantes en Santiago, Chile / Pregnancy and delivery in inmigrant mothers in Santiago, Chile

Introduction: Immigration, mainly from low socio-economic groups is a growing phenomenon in Latin America, including Chile. These groups may have a higher risk for obstetrical and neonatal pathology. Objectives: To know the rate of deliveries in immigrant mothers in Santiago, Chile and their demographics; To compare the weight and height of their children with that of native mothers (NM). Patients and Methods: In a case control studies a database of pregnant women delivering in the Obstetrics Service of San Borja - Arriarán Hospital was analyzed. For every case of an immigrant pregnant mother (IM) 2 control Chilean mothers (NM) were randomly selected, delivering n the same day in every case, between 1/06/2008 and 30/06/2009. Results: From a total number of 6441 deliveries, 495 were of immigrants (7.6 percent of total rate; 89 percent Peruvians) compared with 976 controls. Pregnancy controlled in 97.9 percent in IM and 99.1 percent in NM (NS). A lower risk for teenage pregnancy was observed in IM (6.3 percent versus 15.9 percent; OR: 0.35; IC: 0.23-0.54); the national figure is 14 percent. No difference was observed in the rate of women older than 35 years old (15.0 vs 14.3 percent), or in the primipara (45.8 versus 45.6 percent). IM had less low birth weight (5.4 percent versus 8.4 percent; OR: 0.62; IC 0.39-0.99) (national prevalence: 5.7 percent), without associations to lower teenage pregnancies. Conclusions: Immigrant mothers from low social-economic level in Santiago, Chile, show a lower proportion of teenage pregnancy and infants with low birth weight. There are no differences in the primiparity rate.

Introducción: La inmigración es un fenómeno creciente en Latinoamérica incluido Chile, principalmente de bajo nivel socioeconómico. Estos grupos pueden tener mayor riesgo de patología obstétrica y neonatal. Objetivos: Conocer la proporción de partos en madres inmigrantes en Santiago, Chile; conocer datos demográficos; comparar el peso y talla de los hijos en relación a los de madres nacionales (MN). Pacientes y Métodos: En un estudio de casos y controles se analizó la base de datos con antecedentes de embarazadas atendidas para parto en el Servicio de Obstetricia, Hospital San Borja-Arriarán. Por cada caso de embarazada inmigrante (MI) se seleccionaron aleatoriamente 2 controles de madres chilenas (MN), con parto en el mismo día de cada caso, entre el 1/06/2008 y el 30/06/2009. Resultados: De un total de 6 441 partos hubo 495 de inmigrantes (7,6 por ciento del total; 89 por ciento en peruanas); se compararon con 976 controles. Embarazo controlado en 97,9 por ciento en MI y 99,1 por ciento en MN (NS). Se observó < riesgo de embarazo adolescente en MI (6,3 por ciento vs 15,9 por ciento; OR: 0,35; IC: 0,23-0,54); a nivel nacional esta cifra es de 14 por ciento; sin diferencias en la proporción de > de 35 años (15,0 vs 14,3 por ciento), ni en la de primiparidad (45,8 vs 45,6 por ciento). Las MI tuvieron < bajo peso de nacimiento (5,4 por ciento vs 8,4 por ciento; OR: 0,62; IC 0,39-0,99) (prevalencia nacional: 5,7 por ciento), sin asociación con menor embarazo adolescente. Conclusiones: Las madres inmigrantes de estratos socioeconómicos bajos en Santiago, Chile, presentan una menor proporción de embarazo adolescente y de bajo peso al nacer en sus hijos; sin diferencias en primiparidad.

Obesidad y síndrome metabólico en niños y adolescentes / Obesity and metabolic syndrome in children and adolescens

La obesidad general y en niños es un problema de salud pública con claro aumento a nivel mundial y en Chile. En las edades pediátricas, aparte de sus consecuencias traumatológicas, metabólicas y psicológicas, ya tiene un impacto en el riesgo de enfermedades en las edades adultas. El concepto de síndrome metabólico está en uso hace algunos años en la edad adulta, para aunar factores de riesgo de llegar a desarrollar diabetes tipo II y enfermedad cardiovascular. En pediatría hay suficiente evidencia que son factores predictores de riesgo desde la edad escolar la mayoría de los componentes estudiados en adultos: aumento de circunferencia abdominal, de presión arterial sistólica y diastólica, de triglicéridos y disminución de colesterol HDL sérico. Están en estudio otros componentes del síndrome: resistencia insulínica, adiposidad intraabdominal, hiperuricemia, hiperleptinemia, grosor aumentado de íntimamedia arterial, signos sugerentes de hígado graso. Se justifica el estudio de estos factores en niños y adolescentes obesos y su manejo intensivo por un equipo profesional entrenado.

Obesity in the general population and in children, is a public health issue increasing worldwide and also in Chile. Besides the orthopedic, metabolic and psychological consequences at the pediatric age group, obesity has an evident long term impact on the risk of disease later in life. The term metabolic syndrome (MS) has been used for adults in the past decades, for combined factors associated with the risk of developing diabetes type II or cardiovascular disease at later ages. There is evidence that most of the components of MS for adults are also applicable in children and adolescents: increased abdominal circumference, increased systolic and diastolic blood pressure, increased triglycerides and decreased cholesterol HDL. Complementary features can be: insulin resistance, fatty liver, increased intraabdominal adiposity, hyperuricemia, increased thickness of arterial intima-media, hyperleptinemia. The assessment of these factors is required for all obese children and adolescents and it must be managed by a well trained professional team.

Vitamina D en niños con enfermedades neurológicas en la edad pediátrica / The role of vitamin D in neurological diseases in children

La vitamina D (VD) y sus acciones en el ser humano son objeto de una activa investigación en años recientes, ligada a la descripción de nuevos roles metabólicos, además de su conocida participación en el metabolismo del calcio y del hueso. En niños, algunas enfermedades neurológicas crónicas, como la parálisis cerebral, presentan un riesgo aumentado de deficiencia de VD, explicándose por una ingesta deficiente de ella, una menor exposición solar, requerimiento asociado al proceso de crecimiento, enfermedades intercurrentes y al uso frecuente de drogas antiepilépticas. En esta revisión se analizan los factores asociados a la deficiencia de VD y se plantea la necesidad de evaluar sistemáticamente el estado nutricional de esta vitamina en pacientes con enfermedades neurológicas de riesgo, sus posibles efectos metabólicos, implicancias clínicas y la necesidad de usar alimentos fortificados o suplementación con VD.

Vitamin D (VD) has been object of an active research in the last years, especially in relation with the findings of its new roles, besides its well known participation in calcium and bone metabolism. In children, some chronic neurologic diseases, like cerebral palsy, show an increased risk of VD deficiency, which could be explained by low intake, reduced sun exposure, requirements associated to growth process, intercurrent diseases and frequent use of antiepileptic drugs. In this review, factors associated to VD deficiency are analyzed, pointing to the need of a systematic assessment of the VD nutritional status in patients with neurological diseases associated to this deficiency, its possible metabolic effects, clinical implications and the need of fortified foods or VD supplementation.

Zinc en la terapia del síndrome de déficit de atención e hiperactividad en niños: Un estudio controlado aleatorio preliminar / Zinc in the therapy of the attention-deficit/ hyperactivity disorder in children: A preliminar randomized controlled trial

El síndrome de déficit de atención e hiperactividad (ADHD) es un trastorno neurológico /conductual que se inicia en la infancia. Se ha propuesto que el zinc tendría un potencial rol como terapia adjunta para el ADHD. Nuestro objetivo fue evaluar el efecto de la suplementación con zinc sobre la conducta, como terapia complementaria al metilfenidato, en niños con ADHD. En un estudio controlado, doble ciego, se seleccionaron 40 pacientes con criterios clínicos y psicométricos de ADHD, (31 niños, 9 niñas, 7-14 años de edad). Ellos fueron seleccionados aleatoriamente para recibir ya sea metilfenidato 0,3 mg/kg/d + placebo (sacarosa) (grupo placebo, GPL), o metilfenidato 0,3 mg/kg/d + zinc (sulfato) 10 mg/d (grupo Zn, GZN) por 6 semanas; se excluyeron 4 niños. Se tomó una muestra de 3 mL de sangre en el tiempo 0 y a las 6 semanas para el análisis de Zn plasmático; se aplicó en ambos tiempos a padres y profesores la escala abreviada de Conners para ADHD. Entre los resultados, El Zn plasmático fue normal en el tiempo 0 en ambos grupos, disminuyendo después de 6 sem., especialmente en el grupo GPL (GPL: 95,9 ± 21,5 a 77,9 ± 15,5; GZN: 90.3 ± 9.1 a 85,0 ± 12,0 μg/dl, NS). El test de Conners aplicado por los profesores mostró una aparente mejoría en GZN: GPL: 18 (9-28) a 16 puntos (2-26); GZN: 19 (6-24) a 11 puntos (3-23) (p= 0,07), sin mejoría en el Conners aplicado por los padres: GPL: 19 (7-25) a 13 (3-22); GZN: 19 (7-25) a 11 (2-19). Se concluye que se observa una disminución en las concentraciones plasmáticas de Zn en ambos grupos, pero mayor en el grupo placebo. Con el suplemento de zinc se observa una aparente mejoría en los síntomas de ADHD, de acuerdo con la evaluación de Conners aplicada por profesores. Se requiere avanzar en el estudio de esta probable interacción entre zinc y metilfenidato.

The attention-deficit/hyperactivity disorder (ADHD) is a neurological/behavioral disorder which begins in childhood. Zinc has a potential role as an adjuvant therapy for ADHD. The objective was to evaluate the effect of Zn supplementation on behavior, as a complementary therapy to metylphenidate, in pediatrics patients with ADHD. In a controlled, double blind design, 40 patients with clinical criteria of ADHD (DSMIV) and psychometric evaluation (WISC-R), were selected (31 boys and 9 girls, 7-14 years of age). They were randomized to receive methylphenidate 0.3 mg/kg/d + placebo (sucrose) (group placebo, GPL) or methylphenidate 0.3 mg/kg/d + zinc (sulfate) 10 mg/d (group Zn, GZN) for 6 weeks. A blood sample was drawn at time 0 and 6 weeks, for plasma Zn analysis. The teacher and parent ADHD rating scale (Conners` global index, CGI) was applied at both times. Among the results, plasma Zn was normal at time 0, decreasing especially in the GPL after 6 weeks (GPL: 95.9 ± 21.5 to 77.9 ± 15.5; GZN: 90.3 ± 9.1 to 85.0± 12.0 μg/dL; NS). The CGI by teachers showed a non-significant improvement with Zn: GPL: 18 (9- 28) to 16 points (2-26); GZN: 19 (6-24) to 11 points (3-23) (p=0.07); no significant difference in the CGI by parents by groups was found: GPL: 19 (7-25) to 13 (3- 22); GZN: 19(7-25) to 11(2-19). We conclude that a decrease in plasma Zn levels in both groups was found, greater in the placebo group. An apparent improvement in ADHD signs in children was observed with the Zn supplementation, according to the Conners global index by teachers.

[Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial]. / Zinc en la terapia del sindrome de déficit de atención e hiperactividad en niños. Un estudio controlado aleatorio preliminar.

The attention-deficit/hyperactivity disorder (ADHD) is a neurological/behavioral disorder which begins in childhood. Zinc has a potential role as an adjuvant therapy for ADHD. The objective was to evaluate the effect ofZn supplementation on behavior, as a complementary therapy to metylphenidate, in pediatrics patients with ADHD. In a controlled, double blind design, 40 patients with clinical criteria ofADHD (DSM-IV) and psychometric evaluation (WISC-R), were selected (31 boys and 9 girls, 7-14 years of age). They were randomized to receive methylphenidate 0.3 mg/kg/d + placebo (sucrose) (group placebo, GPL) or methylphenidate 0.3 mg/kg/d + zinc (sulfate) 10 mg/d (group Zn, GZN) for 6 weeks. A blood sample was drawn at time 0 and 6 weeks, for plasma Zn analysis. The teacher and parent ADHD rating scale (Conners' global index, CGI) was applied at both times. Among the results, plasma Zn was normal at time 0, decreasing especially in the GPL after 6 weeks (GPL: 95.9 +/- 21.5 to 77.9 +/- 15.5; GZN: 90.3 +/- 9.1 to 85.0 +/- 12.0 microg/dL; NS). The CGI by teachers showed a non-significant improvement with Zn: GPL: 18 (9-28) to 16 points (2-26); GZN: 19 (6-24) to 11 points (3-23) (p = 0.07); no significant difference in the CGI by parents by groups was found: GPL: 19 (7-25) to 13 (3-22); GZN: 19(7-25) to 11(2-19). We conclude that a decrease in plasma Zn levels in both groups was found, greater in the placebo group. An apparent improvement in ADHD signs in children was observed with the Zn supplementation, according to the Conners global index by teachers.

[Ultrasound measurements of intra-abdominal adiposity and factors associated with cardiovascular risk in obese children]. / Mediciones de adiposidad intraabdominal por ultrasonido y factores asociados con riesgo cardiovascular en niños obesos.

BACKGROUND: Cardiovascular risk factors are commonly present in obese children. AIM: To evaluate the association among radiological measurements of intra-abdominal adipose tissue, and cardiovascular risk factors, in prepuberal obese children. PATIENTS AND METHODS: We evaluated 30 obese (body mass index > p95) children aged 6 to 12 years (15 males). Anthropometry and blood pressure were measured. Subcutaneous and intra-abdominal fat thickness and fat area were measured by ultrasound (US) and computed tomography. Serum insulin, glucose and lipid profile were measured in a fasting blood sample. Homeostasis model assessment (HOMA) was calculated as an index of insulin resistance. RESULTS: There was a significant correlation between US intra-abdominal fat thickness and HOMA (r = 0.47, p < 0.01), serum triglycerides (r = 0.46, p < 0.05) and with positive criteria for metabolic syndrome (r = 0.66, p < 0.01). A receiver operating curve (ROC) analysis showed that, above a cut-off of 45 mm for intra-abdominal fat thickness, US was able to identify insulin resistance with a sensibility and specificity of 79 and 69% respectively and metabolic syndrome with sensibility and specificity of 100 and 67% respectively. US and computed tomography measurements for intra-abdominal fat thickness were significantly correlated (r= 0.62, p < 0.01). CONCLUSIONS: US measurements of intra-abdominal fat thickness identify obesity-associated damage in childhood. Age-specific measurements of intra-abdominal adipose tissue may improve the detection power of this approach.